Samuel M. Hyde

Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness

Rachel K. Voss, Lei Feng, Jeffrey E. Lee et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 65 citations · Full text

Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center

Ioannis Christakis, Wei Qiu, Angelica M. Silva et al. · Hormones and Cancer · 2016 · 41 citations · Full text

Medicine, Thyroid Disease, Pathology +5

Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution

Ioannis Christakis, Wei Qiu, Samuel M. Hyde et al. · Surgery · 2017 · 35 citations

Neuro-oncology, Endocrine Oncology, Pancreatic Cancer +6

Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies

Carolina R C Pieterman, Samuel M. Hyde, Si‐Yuan Wu et al. · Surgery · 2020 · 34 citations · Full text

Clinical Course, Genetic Testing, Mendelian Disorder +7

All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients

Kristin L. Long, Carol J. Etzel, Thereasa A. Rich et al. · Familial Cancer · 2016 · 17 citations

Thyroid Disease, Genetic Epidemiology, Pathology +3